Target Name: LOC105374265
NCBI ID: G105374265
Review Report on LOC105374265 Target / Biomarker Content of Review Report on LOC105374265 Target / Biomarker
LOC105374265
Other Name(s): Uncharacterized LOC105374265 | uncharacterized LOC105374265

LOC105374265: A Potential Drug Target and Biomarker

LOC105374265 is a gene that has not yet been assigned a specific function, but it holds great potential as a drug target and biomarker. The gene is located on chromosome 6 and encodes a protein known as LOC105374265. This protein is involved in various cellular processes, including cell adhesion, migration, and invasion.

LOC105374265 has been identified as a potential drug target due to its involvement in cell signaling pathways. The protein is known to be involved in the NF-kappa signaling pathway, which plays a crucial role in cell growth, differentiation, and survival.

Research has shown that LOC105374265 is a key regulator of the NF-kappa signaling pathway. When NF-kappa signaling is activated, LOC105374265 is recruited to the nucleus and interacts with various transcription factors, including TFAP2, KLF1, and p300. These transcription factors play a crucial role in regulating gene expression and are involved in the development, maintenance, and progression of tissues.

In addition to its involvement in the NF-kappa signaling pathway, LOC105374265 has also been shown to be involved in cell adhesion and migration. The protein has been shown to interact with various adhesion molecules, including E-cadherin, N-cadherin, and vimentin. These interactions play a crucial role in the formation and maintenance of tight junctions, which are essential for the proper functioning of tissues.

The potential drug target for LOC105374265 is based on its involvement in the NF-kappa signaling pathway and its ability to regulate cell adhesion and migration. Drugs that target LOC105374265 and modulate its activity could potentially be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

LOC105374265 has also been identified as a potential biomarker for various diseases. The protein is expressed in a variety of tissues and has been shown to be involved in the development and progression of various diseases, including cancer.

Research has shown that LOC105374265 is involved in the development and progression of breast cancer, neurobladder cancer, and colorectal cancer. The protein has also been shown to be involved in the regulation of cell survival and has been linked to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

The potential drug target for LOC105374265 is based on its involvement in the NF-kappa signaling pathway and its ability to regulate cell adhesion and migration. The protein has also been shown to be involved in the development and progression of various diseases, including cancer and neurodegenerative diseases.

In conclusion, LOC105374265 is a gene that holds great potential as a drug target and biomarker. Its involvement in the NF-kappa signaling pathway and its ability to regulate cell adhesion and migration make it an attractive target for drug development. Further research is needed to fully understand the function of LOC105374265 and its potential as a drug and biomarker.

Protein Name: Uncharacterized LOC105374265

The "LOC105374265 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374265 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120